NCT07527637
- Conditions
- Endocrine System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +20 more
- Locations
-
Not specified
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT03289962
- Conditions
- Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
- Locations
-
- HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
- The Los Angeles Clinic Los Angeles, California, United States
- UCSF Comprehensive Cancer Ctr San Francisco, California, United States
- Stanford Cancer Center Stanford, California, United States
NCT00945009
- Conditions
- Abnormalities, Multiple, Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome, +28 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
NCT02526511
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT00600496
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- Research Site Detroit, Michigan, United States
- Research Site Philadelphia, Pennsylvania, United States
- Research Site Nashville, Tennessee, United States
- Research Site Houston, Texas, United States
NCT02231749
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Local Institution - 0006 Duarte, California, United States
- Local Institution - 0057 La Jolla, California, United States
- Local Institution - 0044 Los Angeles, California, United States
- Local Institution - 0035 Los Angeles, California, United States
NCT04687969
- Conditions
- Adenocarcinoma, Adenocarcinoma of Prostate, Carcinoma, +33 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT04846920
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
- Locations
-
- Beth Israel Deaconess Medical Center ( Site 1002) Boston, Massachusetts, United States
- University of Michigan ( Site 1006) Ann Arbor, Michigan, United States
- Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) Nashville, Tennessee, United States
- University of Texas MD Anderson Cancer Center-Genitourinary Medical Oncology ( Site 1007) Houston, Texas, United States
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
NCT03260894
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Pinnacle Oncology Hematology Scottsdale, Arizona, United States
- Scottsdale Healthcare Scottsdale, Arizona, United States
- Arizona Oncology Associates PC- HOPE Tucson, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States